Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Markovic

Showing results (161-170 of 368) with videos related to

Pageof 37
Sort By:
Journal of Geriatric Oncology|November 21, 2012
Is Age ≥ 70 Years an Important Predictor of Adverse Events Among Patients Enrolled in Metastatic Melanoma Trials? Findings from Pooled Analyses of Therapeutic TrialsAminah Jatoi, Jacob B Allred, Vera J Suman, et al.
Clinical and Translational Radiation Oncology|March 30, 2018
Role of radiotherapy in extracranial metastatic malignant melanoma in the modern eraRyan S Youland, Miran L Blanchard, Roxanna Dronca, et al.
Frontiers in Molecular Biosciences|February 6, 2025
Melanoma-derived cytokines and extracellular vesicles are interlinked with macrophage immunosuppressionShankar Suman, Wendy K Nevala, Alexey A Leontovich, et al.
Oncoimmunology|July 30, 2013
Endogenous tumor-reactive CD8<sup>+</sup> T cells are differentiated effector cells expressing high levels of CD11a and PD-1 but are unable to control tumor growthXin Liu, Rachel M Gibbons, Susan M Harrington, et al.
Lung Cancer (Amsterdam, Netherlands)|August 17, 2013
Up-regulation of pro-angiogenic factors and establishment of tolerance in malignant pleural effusionsElizabeth Ann T Lieser, Gary A Croghan, Wendy K Nevala, et al.
Current Pharmacology Reports|May 27, 2017
Challenges in the delivery of therapies to melanoma brain metastasesGautham Gampa, Shruthi Vaidhyanathan, Brynna-Wilken Resman, et al.
Journal of the American Academy of Dermatology|May 15, 2026
Immunotherapy Utilization and Survival in Metastatic Merkel Cell Carcinoma with Known vs Unknown Primary Tumors: A National Cancer Database StudyHue T T Tran, Thuy M Tran, Duc V Le, et al.
Nutrition and Cancer|January 7, 2000
Comparability of nutrient estimation by three food frequency questionnaires for use in epidemiological studiesS E McCann, M Trevisan, R L Priore, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|December 6, 2017
Immune checkpoint molecules soluble program death ligand 1 and galectin-9 are increased in pregnancyElizabeth Ann L Enninga, Susan M Harrington, Douglas J Creedon, et al.
European Journal of Cancer (Oxford, England : 1990)|July 11, 2017
Adjuvant interferon-α for the treatment of high-risk melanoma: An individual patient data meta-analysisNatalie J Ives, Stefan Suciu, Alexander M M Eggermont, et al.
Pageof 37

Showing results (161-170 of 368) with videos related to

Sort By:
Pageof 37
Journal of Geriatric Oncology|November 21, 2012
Is Age ≥ 70 Years an Important Predictor of Adverse Events Among Patients Enrolled in Metastatic Melanoma Trials? Findings from Pooled Analyses of Therapeutic TrialsAminah Jatoi, Jacob B Allred, Vera J Suman, et al.
Clinical and Translational Radiation Oncology|March 30, 2018
Role of radiotherapy in extracranial metastatic malignant melanoma in the modern eraRyan S Youland, Miran L Blanchard, Roxanna Dronca, et al.
Frontiers in Molecular Biosciences|February 6, 2025
Melanoma-derived cytokines and extracellular vesicles are interlinked with macrophage immunosuppressionShankar Suman, Wendy K Nevala, Alexey A Leontovich, et al.
Oncoimmunology|July 30, 2013
Endogenous tumor-reactive CD8<sup>+</sup> T cells are differentiated effector cells expressing high levels of CD11a and PD-1 but are unable to control tumor growthXin Liu, Rachel M Gibbons, Susan M Harrington, et al.
Lung Cancer (Amsterdam, Netherlands)|August 17, 2013
Up-regulation of pro-angiogenic factors and establishment of tolerance in malignant pleural effusionsElizabeth Ann T Lieser, Gary A Croghan, Wendy K Nevala, et al.
Current Pharmacology Reports|May 27, 2017
Challenges in the delivery of therapies to melanoma brain metastasesGautham Gampa, Shruthi Vaidhyanathan, Brynna-Wilken Resman, et al.
Journal of the American Academy of Dermatology|May 15, 2026
Immunotherapy Utilization and Survival in Metastatic Merkel Cell Carcinoma with Known vs Unknown Primary Tumors: A National Cancer Database StudyHue T T Tran, Thuy M Tran, Duc V Le, et al.
Nutrition and Cancer|January 7, 2000
Comparability of nutrient estimation by three food frequency questionnaires for use in epidemiological studiesS E McCann, M Trevisan, R L Priore, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|December 6, 2017
Immune checkpoint molecules soluble program death ligand 1 and galectin-9 are increased in pregnancyElizabeth Ann L Enninga, Susan M Harrington, Douglas J Creedon, et al.
European Journal of Cancer (Oxford, England : 1990)|July 11, 2017
Adjuvant interferon-α for the treatment of high-risk melanoma: An individual patient data meta-analysisNatalie J Ives, Stefan Suciu, Alexander M M Eggermont, et al.
Pageof 37